The Heart and Estrogen/Progestin Replacement Study: What Have We Learned and What Questions Remain?

Author： Wells G.   Herrington D.M.  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.15, Iss.6, 1999-12, pp. : 419-422

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drugs, Heart Failure and Quality of Life: What Are We Achieving? What Should We Be Trying to Achieve?

By Doba N.   Tomiyama H.   Nakayama T.  

Drugs & Aging, Vol. 14, Iss. 3, 1999-03 ,pp. : 153-163

Adis International

Access to resources Recommend Favorite

The diabetic heart - what is to blame and what can we do?

By  

Inpharma, Vol. 1, Iss. 1302, 2001-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Myc - What We have Learned from Flies

By  

Current Drug Targets, Vol. 10, Iss. 7, 2009-07 ,pp. : 590-601

Bentham Science Publishers

Access to resources Recommend Favorite

Testosterone replacement therapy: what are the risks?

By  

Inpharma, Vol. 1, Iss. 1423, 2004-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

What does istradefylline have to `off'er in PD?

By  

Inpharma, Vol. 1, Iss. 1409, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite